6 years ago

Echopoint Medical Raises €3.5 Million to Improve Heart Disease Diagnosis and Treatment

  • Echopoint Medical Ltd, a London-based spinout company from University College London, has raised €3.5 million to develop optical sensing technology to help doctors and heart disease patients navigate the ‘grey zone’ where the need for treatment is unclear

  • The investment from the UCL Technology Fund, Parkwalk and two grants from Innovate UK will be used to further develop the optical fibre sensors on its microcatheters, as well as its platform, which translates their ultrasound signals into meaningful metrics

  • The company will also complete a 20-30 patient clinical trial.

      • ProblemHealthcare

      "making the decision to implant a stent in patients with coronary heart disease more accurate, reducing the need for unnecessary invasive surgery"

      Solution

      "using optical sensing technology to measure blood pressure and flow, enabling clinicians to precisely assess patients and dramatically reduce stent implants"

      Covered on